The Independent Voice of
European Private Equity

Advanced Search

Impilo-backed Scantox bolts on QPS Neuro

Silvia Iacovcich 4 December 2023

Impilo-backed Scantox has acquired the neuropharmacology division of QPS Austria GmbH, QPS Neuro.

Founded in 1999, QPS Neuro specialises in neurological pharmaceutical research, offering a full range of neurology-related drug development...

Related Articles

Archimed-backed Carso bolts on three firms, focuses on European expansion

07/05/24

Innova closes seventh fund above hard-cap on €407m

07/05/24

Rockpool backs Scottish software testing firm 2i

07/05/24

Abris exits Scanmed in trade sale

07/05/24

Quantum Capital Partners completes exit of Leichtmetall Aluminium

07/05/24

CapMan’s special situations team invests in TerraWise

07/05/24